drugset / Trial / NCT04279535

Topical Vitamin C for Treatment of Basal Cell Cancer

NCT04279535

Phase 0 Completed 25 enrolled Center for Biomedical Research, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

Randomized coomparative trial of a 30% solution of ascorbic acid in 95% dimethylsulfoxide applied topically twice a day for 8 weeks vs 5% imiquimod cream in the treatment biopsy proven basal cell carcinomas inotherwise healthy adult patients. Outcome measure was biopsy proven resolution of the carcinoma.

Timeline

Start
2018-03-01
Primary completion
2019-03-01
Completion
2019-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin C Other / unclassified 30 % Topical

Indications